Irritable Bowel Syndrome Clinical Trials in San Antonio, Texas

4 studies are recruiting for irritable bowel syndrome in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

    The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin) when compared wit…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Southern Star Research Institute, San Antonio, Texas
    Locations
    89 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07545759 on ClinicalTrials.gov

  2. A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

    The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Constipation (IBS-C). The study drug will be administered subcutaneously (SC) (under the skin) when compared …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Southern Star Research Institute, San Antonio, Texas
    Locations
    70 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07545772 on ClinicalTrials.gov

  3. A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

    This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    GSK Investigational Site, San Antonio, Texas
    Locations
    110 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT07519395 on ClinicalTrials.gov

  4. Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

    The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the…

    Stage
    Phase 2
    Ages
    6 to 17
    Site
    Sun Research Institute /ID# 236933, San Antonio, Texas
    Locations
    46 in total
    Run by
    AbbVie

    See if you can join NCT03339128 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.